期刊文献+

7例暴发性1型糖尿病与非急骤起病1型糖尿病的临床特征比较 被引量:1

Compare of the clinical characteristics between fulminant type 1 diabetes and nonfulminant type 1 diabetes
下载PDF
导出
摘要 目的比较分析暴发性1型糖尿病与非急骤起病1型糖尿病临床特征的不同点。方法回顾性比较分析7例暴发性1型糖尿病(F组)与40例非急骤起病1型糖尿病患者[NF组,其中经典1型患者(A组)28例,成人晚发型患者(B组)12例]的一般资料、血糖、血清淀粉酶、血气分析、血电解质指标、C肽水平、胰岛细胞抗体、谷氨酸脱羧酶抗体和胰岛素自身抗体等临床特征的差异。结果F组患者高血糖症状持续时间较NF组明显缩短,存在前驱感染的例数明显多于NF组者,血电解质和酸碱紊乱程度明显重于NF组(均P〈0.05或0.01);F组患者糖化血红蛋白水平较A组和B组患者明显降低(P〈0.01);F组患者入院时血肌酐水平较A组患者明显增高(P〈0.05)。结论暴发性1型糖尿病患者的代谢紊乱程度较非急骤起病的1型糖尿病者更严重。 Objective To investigate the different clinical characteristics between fulminant type 1 diabetes and nonfulminant type 1 diabetes. Methods Clinical data of 47 cases of type 1diabetes diagnosed from January 2000 to January 2009 were retrospectively reviewed. Seven cases fell into the criteria of fulminant type 1 diabetes (group F, n= 7), and the remaining 40 cases included 28 patients with acute onset (group A) and 12 with slow onset (group S). The clinical characteristics were compared among three groups. Results Compare to nonfulminat group patients in group F appeared shorter duration of symptoms (4d vs 694d, P 〈 0.01), higher blood glucose, lower HCO3^- (5.3 mmol/L vs 15.6 mmol/L, P 〈 0.01) and BE(-21.9 mmol/L vs -10.24mmol/L, P 〈 0.05), higher serum potassium (4.82 mmol/L vs 4.10 mmol/L, P 〈 0.001), and lower HbAlc (6.5% vs. 12.9%, P〈0.001). Conclusion Fulminant type 1diabetes showed severer metabolic derangements than nonfulminant diabetes.
出处 《浙江医学》 CAS 2009年第5期576-578,581,共4页 Zhejiang Medical Journal
关键词 糖尿病 胰岛素依赖型 糖尿病酮症酸中毒 胰酶 自身抗体 Diabetes mellitus insulin-dependent Diabetic ketoacidosis Pancreatin Autoantibodies
  • 相关文献

参考文献11

  • 1Imagawa A,Hanafusa T,Miyagawa J,et al.A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies[J].N Engl J Med,2000,342:301-307.
  • 2Kawasaki E,Eguchi K.Current aspects on the clinical immunology and genetics of autoimmune diabetes in Japan[J].Diabetes Res Clin Pract.2007,77:s104-109.
  • 3Kawasaki E,Matsuura N,Eguchi K.Type 1 diabetes in Japan[J].Diabetologia,2006,49(5):828-836.
  • 4Imagawa A,Hanafusa T,Uchigata Y,et al.Fulminant type 1 diabetes.A nationwide survey in Japan[J].Diabetes Care,2003,26:2345-2352.
  • 5张弛,周智广,张冬梅,杨晓琳,周敏,林健,黄干,王建平.急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征[J].中华医学杂志,2005,85(14):967-971. 被引量:46
  • 6Hanafusa T.Imagawa A.Insulitis in human type 1 diabetes[J].Ann N Y Acad Sci,2008,1150:297-299.
  • 7Yadav D,Nair S,Norkus E P,et al.Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis:incidence and correlation with biochemical abnormalities[J].Am J Gastroenterol,2000,95:3123-3128.
  • 8Obi N,Katabami T,Asai S,et al.Fulminant type 1 diabetes complicated by leukemoid reaction[J].intern Med,2008,47:847-851.
  • 9Takaike H,Uchigata Y,lwamoto Y,et al.Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus[J].Ann Med,2008,40:395-400.
  • 10Murase Y,Imagawa A,Hanafusa T,et al.FuIminant type 1 diabetes as a high risk group for diabetic microangiopathy--anationwide 5-year-study in Japan[J].Diabetologia,2007,50:531-537.

二级参考文献19

  • 1Taniyama M, Katsumata R, Aoki K, et al. A Fillipino patient with fulminant type 1 diabetes. Diabetes Care, 2004, 27:842-843.
  • 2Imagawa A,- Hanafusa T, Uchigata Y, et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia,2005, 48:294-300.
  • 3Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia,2005, 48:290-293.
  • 4Yadav D, Nair S, Norkus EP, et al. Nonspecitic hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol,2000, 95:3123-3128.
  • 5Semakula C, Vandewalle CL, Van Schravendijk CF, et al.Abnormal pancreatic enzyme activities in more than twenty-five percent recent onset insulin-dependent diabetic patients: association of hyperlipasemia with high titre islet-cell antibodies. Pancreas,1996,12:321-333.
  • 6Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997,20:1183-1197.
  • 7Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15:539-553.
  • 8Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med, 2000, 342:301-307.
  • 9Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes. A nationwide survey in Japan. Diabetes Care, 2003, 26:2345-2352.
  • 10Maldonado MM, Hampe CS, Gaur LK, et al. Ketosis-Prone diabetes : dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003,88:5090-5098.

共引文献45

同被引文献18

  • 1IMAGAWA A,HANAFUSA T, MIYAGAWA J,et al. Anovel subtype of type 1 diabetes mellitus characterized by arapid onset and an absence of diabetes-related antibodies. ()-saka IDDM Study Group [J]. N Engl J Med, 2000,342(5);301-307.
  • 2IMAGAWA A, HANAFUSA T. Fulminant type 1 diabetesmellitus immunoendocrinology : scientific and clinical aspects[M]. New York: Humana Press, 2011: 331-342.
  • 3IMAGAWA A, HANAFUSA T. Fulminant type 1 diabetes*-an important subtype in East Asia [J]. Diabetes Metab ResRev, 2011, 27(8):959-964.
  • 4IMAGAWA A, HANAFUSA T,UCHIGATA Y, et al.Fulminant type 1 diabetes: a nationwide survey in japan [J]. Diabetes Care, 2003, 26(8):2345-2352.
  • 5CHO Y M, KIM J T, KO K S,et al. Fulminant type 1 dia-betes in korea: High prevalence among patients with adult-onset type 1 diabetes [J]. Diabetologia,2007,50(] 1) : 2276-2279.
  • 6MOREAU C, DRUI D, ARNAULT-OUARY G, et al. Ful-minant type 1 diabetes in Caucasians: a report of three cases[J]. Diabetes Metab, 2008,34(5): 529-532.
  • 7SHAW E H,OBRIEN K E, HAYMAN R G. Fulminant de-velopment of diabetes mellitus presenting as diabetic ketoaci-dosis in a pregnant Caucasian woman [J]. Arch Dis Child Fe-tal Neonatal Ed, 2010,95(Suppl 1): Fa59.
  • 8ZHENG C,ZHOU Z, YANG L,et al. Fulminant type 1 dia-betes mellitus exhibits distinct clinical and autoimmunity fea-tures from classical type 1 diabetes mellitus in Chinese [J].Diabetes Metab Res Rev, 2011,27(1): 70-78.
  • 9SEINO Y, YAMAUCHI M, HIRAI C, et al. A case of ful-minant type 1 diabetes associated with mexiletine hypersensi-tivity syndrome [J]. Diabet Med, 2004, 21(10) : 1156-1157.
  • 10CHIOU C C, CHUNG W H,HUNG S I, et al. Fulminanttype 1 diabetes mellitus caused by drug hypersensitivity syn-drome with human herpesvirus 6 infection [J]. J Am AcadDermatol, 2006 , 54(2 Suppl) : S14-S17.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部